Cetuximab Market, Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: CD0F0CB0EE35EN
Market Monitor Global

Abstracts

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer.

This report contains market size and forecasts of Cetuximab in global, including the following market information:

Global Cetuximab Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cetuximab Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Cetuximab companies in 2021 (%)

The global Cetuximab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

100 mg/50 mL Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cetuximab include Eli Lilly and Merck etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cetuximab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cetuximab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cetuximab Market Segment Percentages, by Type, 2021 (%)

• 100 mg/50 mL Injection
• 200 mg/100 mL Injection

Global Cetuximab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cetuximab Market Segment Percentages, by Application, 2021 (%)

• Head and Neck Cancer
• Metastatic Colorectal Cancer

Global Cetuximab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cetuximab Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cetuximab revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Cetuximab revenues share in global market, 2021 (%)

Key companies Cetuximab sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Cetuximab sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cetuximab Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cetuximab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CETUXIMAB OVERALL MARKET SIZE

2.1 Global Cetuximab Market Size: 2021 VS 2028
2.2 Global Cetuximab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cetuximab Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Cetuximab Players in Global Market
3.2 Top Global Cetuximab Companies Ranked by Revenue
3.3 Global Cetuximab Revenue by Companies
3.4 Global Cetuximab Sales by Companies
3.5 Global Cetuximab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cetuximab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cetuximab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cetuximab Players in Global Market
  3.8.1 List of Global Tier 1 Cetuximab Companies
  3.8.2 List of Global Tier 2 and Tier 3 Cetuximab Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cetuximab Market Size Markets, 2021 & 2028
  4.1.2 100 mg/50 mL Injection
  4.1.3 200 mg/100 mL Injection
4.2 By Type - Global Cetuximab Revenue & Forecasts
  4.2.1 By Type - Global Cetuximab Revenue, 2017-2022
  4.2.2 By Type - Global Cetuximab Revenue, 2023-2028
  4.2.3 By Type - Global Cetuximab Revenue Market Share, 2017-2028
4.3 By Type - Global Cetuximab Sales & Forecasts
  4.3.1 By Type - Global Cetuximab Sales, 2017-2022
  4.3.2 By Type - Global Cetuximab Sales, 2023-2028
  4.3.3 By Type - Global Cetuximab Sales Market Share, 2017-2028
4.4 By Type - Global Cetuximab Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cetuximab Market Size, 2021 & 2028
  5.1.2 Head and Neck Cancer
  5.1.3 Metastatic Colorectal Cancer
5.2 By Application - Global Cetuximab Revenue & Forecasts
  5.2.1 By Application - Global Cetuximab Revenue, 2017-2022
  5.2.2 By Application - Global Cetuximab Revenue, 2023-2028
  5.2.3 By Application - Global Cetuximab Revenue Market Share, 2017-2028
5.3 By Application - Global Cetuximab Sales & Forecasts
  5.3.1 By Application - Global Cetuximab Sales, 2017-2022
  5.3.2 By Application - Global Cetuximab Sales, 2023-2028
  5.3.3 By Application - Global Cetuximab Sales Market Share, 2017-2028
5.4 By Application - Global Cetuximab Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cetuximab Market Size, 2021 & 2028
6.2 By Region - Global Cetuximab Revenue & Forecasts
  6.2.1 By Region - Global Cetuximab Revenue, 2017-2022
  6.2.2 By Region - Global Cetuximab Revenue, 2023-2028
  6.2.3 By Region - Global Cetuximab Revenue Market Share, 2017-2028
6.3 By Region - Global Cetuximab Sales & Forecasts
  6.3.1 By Region - Global Cetuximab Sales, 2017-2022
  6.3.2 By Region - Global Cetuximab Sales, 2023-2028
  6.3.3 By Region - Global Cetuximab Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Cetuximab Revenue, 2017-2028
  6.4.2 By Country - North America Cetuximab Sales, 2017-2028
  6.4.3 US Cetuximab Market Size, 2017-2028
  6.4.4 Canada Cetuximab Market Size, 2017-2028
  6.4.5 Mexico Cetuximab Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Cetuximab Revenue, 2017-2028
  6.5.2 By Country - Europe Cetuximab Sales, 2017-2028
  6.5.3 Germany Cetuximab Market Size, 2017-2028
  6.5.4 France Cetuximab Market Size, 2017-2028
  6.5.5 U.K. Cetuximab Market Size, 2017-2028
  6.5.6 Italy Cetuximab Market Size, 2017-2028
  6.5.7 Russia Cetuximab Market Size, 2017-2028
  6.5.8 Nordic Countries Cetuximab Market Size, 2017-2028
  6.5.9 Benelux Cetuximab Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Cetuximab Revenue, 2017-2028
  6.6.2 By Region - Asia Cetuximab Sales, 2017-2028
  6.6.3 China Cetuximab Market Size, 2017-2028
  6.6.4 Japan Cetuximab Market Size, 2017-2028
  6.6.5 South Korea Cetuximab Market Size, 2017-2028
  6.6.6 Southeast Asia Cetuximab Market Size, 2017-2028
  6.6.7 India Cetuximab Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Cetuximab Revenue, 2017-2028
  6.7.2 By Country - South America Cetuximab Sales, 2017-2028
  6.7.3 Brazil Cetuximab Market Size, 2017-2028
  6.7.4 Argentina Cetuximab Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Cetuximab Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Cetuximab Sales, 2017-2028
  6.8.3 Turkey Cetuximab Market Size, 2017-2028
  6.8.4 Israel Cetuximab Market Size, 2017-2028
  6.8.5 Saudi Arabia Cetuximab Market Size, 2017-2028
  6.8.6 UAE Cetuximab Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Cetuximab Major Product Offerings
  7.1.4 Eli Lilly Cetuximab Sales and Revenue in Global (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Cetuximab Major Product Offerings
  7.2.4 Merck Cetuximab Sales and Revenue in Global (2017-2022)
  7.2.5 Merck Key News

8 GLOBAL CETUXIMAB PRODUCTION CAPACITY, ANALYSIS

8.1 Global Cetuximab Production Capacity, 2017-2028
8.2 Cetuximab Production Capacity of Key Manufacturers in Global Market
8.3 Global Cetuximab Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 CETUXIMAB SUPPLY CHAIN ANALYSIS

10.1 Cetuximab Industry Value Chain
10.2 Cetuximab Upstream Market
10.3 Cetuximab Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Cetuximab Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Cetuximab in Global Market
Table 2. Top Cetuximab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cetuximab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cetuximab Revenue Share by Companies, 2017-2022
Table 5. Global Cetuximab Sales by Companies, (K Units), 2017-2022
Table 6. Global Cetuximab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cetuximab Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Cetuximab Product Type
Table 9. List of Global Tier 1 Cetuximab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cetuximab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cetuximab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cetuximab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cetuximab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cetuximab Sales (K Units), 2017-2022
Table 15. By Type - Global Cetuximab Sales (K Units), 2023-2028
Table 16. By Application – Global Cetuximab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cetuximab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cetuximab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cetuximab Sales (K Units), 2017-2022
Table 20. By Application - Global Cetuximab Sales (K Units), 2023-2028
Table 21. By Region – Global Cetuximab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cetuximab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cetuximab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cetuximab Sales (K Units), 2017-2022
Table 25. By Region - Global Cetuximab Sales (K Units), 2023-2028
Table 26. By Country - North America Cetuximab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cetuximab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cetuximab Sales, (K Units), 2017-2022
Table 29. By Country - North America Cetuximab Sales, (K Units), 2023-2028
Table 30. By Country - Europe Cetuximab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cetuximab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cetuximab Sales, (K Units), 2017-2022
Table 33. By Country - Europe Cetuximab Sales, (K Units), 2023-2028
Table 34. By Region - Asia Cetuximab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cetuximab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cetuximab Sales, (K Units), 2017-2022
Table 37. By Region - Asia Cetuximab Sales, (K Units), 2023-2028
Table 38. By Country - South America Cetuximab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cetuximab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cetuximab Sales, (K Units), 2017-2022
Table 41. By Country - South America Cetuximab Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Cetuximab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cetuximab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cetuximab Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Cetuximab Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Cetuximab Product Offerings
Table 48. Eli Lilly Cetuximab Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Cetuximab Product Offerings
Table 51. Merck Cetuximab Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Cetuximab Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 53. Global Cetuximab Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Cetuximab Production by Region, 2017-2022 (K Units)
Table 55. Global Cetuximab Production by Region, 2023-2028 (K Units)
Table 56. Cetuximab Market Opportunities & Trends in Global Market
Table 57. Cetuximab Market Drivers in Global Market
Table 58. Cetuximab Market Restraints in Global Market
Table 59. Cetuximab Raw Materials
Table 60. Cetuximab Raw Materials Suppliers in Global Market
Table 61. Typical Cetuximab Downstream
Table 62. Cetuximab Downstream Clients in Global Market
Table 63. Cetuximab Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Cetuximab Segment by Type
Figure 2. Cetuximab Segment by Application
Figure 3. Global Cetuximab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cetuximab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cetuximab Revenue, 2017-2028 (US$, Mn)
Figure 7. Cetuximab Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cetuximab Revenue in 2021
Figure 9. By Type - Global Cetuximab Sales Market Share, 2017-2028
Figure 10. By Type - Global Cetuximab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cetuximab Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Cetuximab Sales Market Share, 2017-2028
Figure 13. By Application - Global Cetuximab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cetuximab Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Cetuximab Sales Market Share, 2017-2028
Figure 16. By Region - Global Cetuximab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cetuximab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cetuximab Sales Market Share, 2017-2028
Figure 19. US Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cetuximab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cetuximab Sales Market Share, 2017-2028
Figure 24. Germany Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 25. France Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cetuximab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cetuximab Sales Market Share, 2017-2028
Figure 33. China Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 37. India Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cetuximab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cetuximab Sales Market Share, 2017-2028
Figure 40. Brazil Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cetuximab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cetuximab Sales Market Share, 2017-2028
Figure 44. Turkey Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cetuximab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cetuximab Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Cetuximab by Region, 2021 VS 2028
Figure 50. Cetuximab Industry Value Chain
Figure 51. Marketing Channels